- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06164886
Information Flow of Waiting List for Scheduled Surgical Admissions
October 18, 2024 updated by: Istituto Ortopedico Rizzoli
Definition and experimentation of the aforementioned information flow within the Regions participating in the three-year project, a Technical Subgroup was identified on a voluntary basis in charge of defining the design and following the experimental operational phases
Study Overview
Study Type
Observational
Enrollment (Actual)
507
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
BO
-
Bologna, BO, Italy, 40136
- Istituto Ortopedico Rizzoli
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
all adult patients placed on the waiting list with the NHS for surgery scheduled at the centre
Description
Inclusion Criteria:
- all adult patients
Exclusion Criteria:
- Minor patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Sperimental
Patient on the waiting list for scheduled surgical admissions
|
patient on the waiting list for scheduled surgical admissions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Verification of the completeness of the data entered within the flow to guarantee ex Ante monitoring of the waiting list for scheduled surgical hospitalization
Time Frame: At baseline (Day 0)
|
At baseline (Day 0)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2023
Primary Completion (Actual)
September 30, 2024
Study Completion (Actual)
September 30, 2024
Study Registration Dates
First Submitted
December 1, 2023
First Submitted That Met QC Criteria
December 1, 2023
First Posted (Actual)
December 11, 2023
Study Record Updates
Last Update Posted (Actual)
October 21, 2024
Last Update Submitted That Met QC Criteria
October 18, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- LIDIA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.